Case report of three Chlamydia psittaci pneumonia diagnosed with metagenome next-generation sequencing and literature review

张伟,和平,石婕,赵凯凯,冯雁京,王煜,孙秀珍
DOI: https://doi.org/10.3760/cma.j.cn131368-20220330-00259
2022-01-01
Abstract:Objective:To investigate the clinical characteristics, diagnosis, and treatment of Chlamydia psittaci infection.Methods:The clinical data and the sequence of Chlamydia psittaci pneumonia DNA were collected from three cases of Chlamydia psittacosis, and their diagnosis, treatment, and prognosis were reviewed. Combined with relevant domestic and foreign literatures, the clinical characteristics, diagnosis, treatment, and prognosis of the disease were summarized. The antimicrobial resistance gene database was used to screen resistance genes.Results:In this study, we accurately diagnosed Chlamydia psittaci infection through examination of alveolar lavage fluid by metagenomics next-generation sequencing (mNGS). The symptoms of patients were significantly relieved under the treatment of moxifloxacin and doxycycline.No antimicrobial resistance gene was discovered in three cases.Conclusions:The main manifestations of Chlamydia psittaci pneumonia are fever and shortness of breath.The disease progresses rapidly, but the clinical symptoms and results of routine laboratory examination are lack of specificity. The contact history of birds and mammals plays an important role in diagnosis. Test of alveolar lavage fluid via mNGS can help clinical diagnosis, and early treatment with doxycycline and Quinolone antimicrobial agents produces a significant effect.
What problem does this paper attempt to address?